For the year ending 2025-12-31, ESLA has $3,176,975 in assets. $13,543,033 in debts. $1,384,302 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 1,384,302 | |||
| Prepaid expenses and other receivable | 292,673 | |||
| Total current assets | 1,676,975 | |||
| Prepaid expenses, related party , non-current | 1,500,000 | |||
| Total assets | 3,176,975 | |||
| Accounts payable - related party | 554,781 | |||
| Other payables and accrued liabilities | 238,414 | |||
| Accrued liability - related party | 12,393,333 | |||
| Derivative liabilities | 356,505 | |||
| Total current liabilities | 13,543,033 | |||
| Total liabilities | 13,543,033 | |||
| Common stock, 0.0001 par value 250,000,000 shares authorized 38,486,219 and 36,680,870 shares issued as of december 31, 2025 and 2024, respectively | 3,849 | |||
| Additional paid-in capital | 27,219,287 | |||
| Accumulated deficit | -36,990,815 | |||
| Treasury stock, at cost 515,281 and 486,979 shares as of december 31, 2025 and 2024, respectively | 598,379 | |||
| Total stockholders (deficit) equity | -10,366,058 | |||
| Total liabilities and stockholders (deficit) equity | 3,176,975 | |||
Estrella Immunopharma, Inc. (ESLA)
Estrella Immunopharma, Inc. (ESLA)